Neoss Group signs collaboration agreement with Sweden-based Osstell AB

Neoss Group, a pioneer in dental implant solutions, announced the partnership with Osstell AB, a global organization from Gothenburg, Sweden.

This dynamic collaboration marks a significant milestone in the dental industry, uniting the strengths of the two organizations to develop innovative products that will improve patient care worldwide.

Osstell AB is renowned for its unwavering commitment to empowering dentists and dental surgeons globally, aiming to enhance the safety, efficacy, and success rates of implant treatments. With this collaboration Neoss Group and Osstell AB solidify their positions as key players in the dental industry.

"Teaming up with Osstell, the world leader in Resonance Frequency Analysis, allows us to fuse our cutting-edge dental implant solutions with their extensive knowledge in the field of dental implant stability and osseointegration," said Dr. Robert Gottlander, president and CEO of Neoss Group.

"Collaborating with Neoss Group opens up new possibilities for advancing implant treatments and empowering dental professionals globally. We are excited about the potential it holds, and the positive outcomes this collaboration will bring to clinicians and patients worldwide," said Malin Gustavsson, CEO of Osstell AB.

Neoss Group and Osstell AB are excited about the transformative impact this partnership will have on the dental implant market, benefiting both clinicians and patients. Together, Neoss Group and Osstell AB will strive to deliver exceptional implant solutions and advance oral health.

Neoss was founded with a vision to enhance dental implant treatments for both clinicians and patients. With their extensive expertise in dental implant procedures, we are committed to develop user-friendly and costeffective solutions that enhance the efficiency of dental professionals and improve patient outcomes.

Osstell is the global leader in implant stability measurement and osseointegration progress monitoring. Osstell was formed in 1999 to commercialize an invention using Resonance Frequency Analysis (RFA) to determine the clinical status of a dental implant.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!